| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996417247503316 |
|
|
Titolo |
Disease and diagnosis |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Bandar Abbas, Hormozgan, Iran : , : Hormozgan University of Medical Sciences, , [2020]- |
|
|
|
|
|
|
|
|
|
ISSN |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Soggetti |
|
Medical sciences |
Clinical medicine |
Diseases |
Diagnosis |
Disease |
Prognosis |
Health |
Periodical |
Periodicals. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Periodico |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910253862903321 |
|
|
Autore |
Ang Meidjie |
|
|
Titolo |
Metabolic Response of Slowly Absorbed Carbohydrates in Type 2 Diabetes Mellitus / / by Meidjie Ang |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2016.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (149 p.) |
|
|
|
|
|
|
Collana |
|
SpringerBriefs in Systems Biology, , 2193-4746 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Systems biology |
Biological systems |
Endocrinology |
Systems Biology |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Introduction -- Background and Objectives -- Methods -- Results -- Discussion -- Summary. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This SpringerBrief focuses on clinical nutrition research, particularly on the effects of slowly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes. Slowlyabsorbed carbohydrates will cause gradual increases in blood glucose and insulin levels, and may therefore be effective as part of a treatment strategy for glycemic control and reduction of cardiovascular complications in type 2 diabetes. |
|
|
|
|
|
|
|
| |